Neuralink received US FDA approval for the Blindsight chip in September 2024. It was designated as a 'breakthrough device'.

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential ...

Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in ...

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Elon Musk said his brain chip startup Neuralink aims to have its artificial visual prosthesis, Blindsight, implanted in a ...

Blindsight received ‘breakthrough’ status from the US Food and Drug Administration (FDA) in September last year. It has been ...